Featured Santa Monica becomes hotbed for cancer fighting biotech industry Huge breakthroughs are being made in the biotechnology research field that could change the future o By Clara Harter / 5 Jul 2021
News Gilead to pay $11.9B for cancer treatment developer Kite Gilead Sciences will pay $11.9 billion in cash to buy Kite Pharma and plant a stake in an emerging area of cancer treatments that train a patient's By Editor / 28 Aug 2017
business Hines looking to reoccupy Papermate site BERGAMOT AREA — The developer behind last year's most controversial project is looking to reoccupy the site, which is currently dormant, according email exchanges obtained by the Daily Press. By David Mark Simpson / 8 Jan 2015
